跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
阿司匹林双嘧达莫缓释胶囊 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Aspirin and Dipyridamole Sustained-release Capsules
Approved
化学药品
Aspirin and Dipyridamole Sustained-release Capsules
蓬莱诺康药业有限公司
🇨🇳 National Medical Products Administration
Approval Date
Apr 24, 2020
Approval ID
7LeafiPSDhX
Company
蓬莱诺康药业有限公司
Type
化学药品
Approval Details
Approval Id
7LeafiPSDhX
Approval Number
国药准字H20100181
Generic Name
阿司匹林双嘧达莫缓释胶囊
Generic Name En
Aspirin and Dipyridamole Sustained-release Capsules
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
双嘧达莫200mg/阿司匹林25mg
Reg Date
2020-04-24
Company Name
蓬莱诺康药业有限公司
Production Company Name
蓬莱诺康药业有限公司
Production Company Address
山东省蓬莱市金创路118号
Company Detail Path
/organization/peng-lai-nuo-kang-yao-ye-you-xian-gong-si
Production Company Detail Path
/organization/peng-lai-nuo-kang-yao-ye-you-xian-gong-si
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Apr 24, 2020
Approval ID
7LeafiPSDhX
Type
化学药品
Back to NMPA Approvals